Mexico faces rising threat from counterfeit medicines and AI fraud

Mexico is facing a growing threat from the illegal pharmaceutical market, which is projected to reach 38.5 billion pesos by the end of 2026. The National Union of Pharmacy Entrepreneurs (UNEFARM) reports a 6% increase in illegal trade, involving stolen, expired, and counterfeit products.

Industry leaders warn that criminals are increasingly using artificial intelligence to sophisticatedly deceive consumers. These tactics include using AI-generated videos, fake profiles, and impersonating medical specialists to create a false sense of legitimacy for unregulated products. Beyond digital fraud, the illegal market is fueled by theft and the smuggling of counterfeit goods through the southern border.

In response to specific threats, the Federal Commission for Protection against Sanitary Risks (Cofepris) has issued sanitary alerts for several products. Counterfeit versions of Saizen (somatropin), Bedoyecta (B complex), and Buscapina Compositum have been identified, along with the adulteration of the medical device Granulox. Authorities urge consumers to avoid these specific lots due to risks regarding sterility, safety, and efficacy.